Physician profile
Tory B Speert
NPI 1972843548
$11,341.57
in general payments reported to CMS, 2019-2025
24 companies · $991 in 2025
The $991 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,668 · 2020: $1,383 · 2021: $1,543 · 2022: $2,298 · 2023: $1,732 · 2024: $725 · 2025: $991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,448.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $3,579.38 | 2019-2024 | Senza |
| Boston Scientific Corporation | $3,402.29 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Vertos Medical, INC. | $1,272.08 | 2019-2024 | Mild Device Kit |
| Abbott Laboratories | $1,127.56 | 2019-2025 | Proclaim |
| Saluda Medical Americas, INC. | $640.00 | 2024-2025 | Evoke |
| Ferring Pharmaceuticals INC. | $412.84 | 2019-2025 | Euflexxa |
| Prodigy Surgical Distribution, INC. | $199.93 | 2025 | |
| Depuy Synthes Sales INC. | $104.53 | 2019-2024 | Inhance |
| Globus Medical, INC. | $95.51 | 2025 | Senza |
| Pacira Therapeutics, INC. | $76.73 | 2019 | |
| Relievant Medsystems, INC. | $75.43 | 2021-2022 | |
| Horizon Therapeutics Plc | $49.54 | 2020 | |
| Bioventus LLC | $42.05 | 2020-2025 | Xcell |
| Arbor Pharmaceuticals, INC. | $40.49 | 2019-2022 | |
| Organogenesis INC. | $39.96 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $38.11 | 2019 | |
| Foundation Fusion Solutions, LLC | $27.59 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $23.47 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $23.18 | 2023 | Seglentis |
| Scilex Pharmaceuticals INC. | $21.72 | 2022 | |
| Ibsa Pharma INC. | $20.70 | 2025 | Licart, Tirosint, Flector |
| Pfizer INC. | $13.85 | 2019 | |
| Medtronic USA, INC. | $13.18 | 2020 | |
| Spr Therapeutics, INC | $1.45 | 2024 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tory Speert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.